GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 282 filers reported holding GUARDANT HEALTH INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,899,296 | -20.1% | 97,817 | -3.5% | 0.01% | -10.0% |
Q2 2023 | $3,627,972 | +45.3% | 101,340 | -4.9% | 0.01% | +42.9% |
Q1 2023 | $2,497,579 | -21.2% | 106,552 | -8.5% | 0.01% | -30.0% |
Q4 2022 | $3,167,984 | -51.8% | 116,470 | -4.5% | 0.01% | -52.4% |
Q3 2022 | $6,567,000 | +27.2% | 122,002 | -4.7% | 0.02% | +61.5% |
Q2 2022 | $5,164,000 | -29.9% | 128,004 | +15.2% | 0.01% | -13.3% |
Q1 2022 | $7,363,000 | +573.7% | 111,153 | +917.6% | 0.02% | +650.0% |
Q4 2021 | $1,093,000 | -22.3% | 10,923 | -3.0% | 0.00% | -33.3% |
Q3 2021 | $1,407,000 | +5.6% | 11,256 | +4.9% | 0.00% | 0.0% |
Q2 2021 | $1,332,000 | -16.2% | 10,727 | +3.0% | 0.00% | 0.0% |
Q1 2021 | $1,590,000 | +16.8% | 10,417 | -1.4% | 0.00% | 0.0% |
Q4 2020 | $1,361,000 | +20.9% | 10,560 | +4.9% | 0.00% | 0.0% |
Q3 2020 | $1,126,000 | +42.2% | 10,070 | +3.2% | 0.00% | +50.0% |
Q2 2020 | $792,000 | +126.9% | 9,760 | +94.8% | 0.00% | +100.0% |
Q1 2020 | $349,000 | -14.9% | 5,010 | -4.6% | 0.00% | 0.0% |
Q4 2019 | $410,000 | +23.9% | 5,250 | +1.4% | 0.00% | 0.0% |
Q3 2019 | $331,000 | -21.6% | 5,180 | +5.9% | 0.00% | 0.0% |
Q2 2019 | $422,000 | – | 4,891 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |